Is Processa Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: PCSA) stock is to Buy PCSA stock.
Out of 2 analysts, 0 (0%) are recommending PCSA as a Strong Buy, 2 (100%) are recommending PCSA as a Buy, 0 (0%) are recommending PCSA as a Hold, 0 (0%) are recommending PCSA as a Sell, and 0 (0%) are recommending PCSA as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year PCSA price target, the average PCSA price target is $6.00, with the highest PCSA stock price forecast at $8.00 and the lowest PCSA stock price forecast at $4.00.
On average, Wall Street analysts predict that Processa Pharmaceuticals's share price could reach $6.00 by Apr 25, 2025. The average Processa Pharmaceuticals stock price prediction forecasts a potential upside of 179.07% from the current PCSA share price of $2.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.